Clinical Trials Browser

Phase 1 × Leukemia, Myeloid, Acute × AGS67E × Clear all

NCT02610062 2024-11-01

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute